|
TW201922233A
|
|
Synthesis of antibacterial aminoglycoside analogs
|
|
WO2019194858A1
|
|
Modular synthesis of aminoglycosides
|
|
WO2019046126A1
|
|
Aminoglycosides and uses thereof
|
|
WO2018140827A1
|
|
Reporter microorganisms and uses thereof
|
|
EP3494143A2
|
|
Plazomicin antibodies and methods of use
|
|
WO2018023081A1
|
|
6-phenylpyrido[2,3-d]pyrimidine compounds as antibacterial agents
|
|
AU2017295866A1
|
|
Combination of ceftibuten and clavulanic acid for use in the treatment of bacterial infections
|
|
TW201803847A
|
|
Antibacterial agents
|
|
US2019031743A1
|
|
Screening methods for identifying antibodies that bind cell surface epitopes
|
|
WO2014165075A1
|
|
Antibacterial agents
|
|
WO2013170165A1
|
|
Antibacterial agents
|
|
WO2013170030A1
|
|
Antibacterial agents
|
|
TW201315710A
|
|
Polymorphs of N-((S)-3-amino-1-(hydroxyamino)-3-methyl-1-oxobutan-2-yl)-4-(((1R,2R)-2-(hydroxymethyl)cyclopropyl)buta-1,3-diynyl)benzamide
|
|
CN103282370A
|
|
Antibacterial amiinoglycoside analogs
|
|
AU2011367819A1
|
|
Hydroxamic acid derivatives and their use in the treatment of bacterial infections
|
|
WO2011044502A1
|
|
Antibacterial aminoglycoside analogs
|
|
WO2011044503A1
|
|
Antibacterial aminoglycoside analogs
|
|
CN102596981A
|
|
Antibacterial aminoglycoside analogs
|
|
WO2011044538A1
|
|
Antibacterial aminoglycoside analogs
|
|
WO2011044498A1
|
|
Antibacterial aminoglycoside analogs
|
